Literature DB >> 6901475

Antibiotic-resistant Staphylococcus epidermidis in patients undergoing cardiac surgery.

G L Archer, M J Tenenbaum.   

Abstract

Staphylococcus epidermidis isolates containing subpopulations resistant to 100 microgram of methicillin per ml were found on the chests of only 3 of 80 (4%) patients before cardiac surgery, whereas these highly resistant staphylococci were isolated from the chest wounds of 43 of 80 (54%) patients 5 days postoperatively. The percentage of patients colonized with methicillin-resistant S. epidermidis increased with time postoperatively. Methicillin-resistant postoperative isolates also contained organisms resistant to other antibiotics frequently used during these patients' hospitalizations. The percentages of patients with organisms resistant to various antibiotics were: nafcillin (100%), penicillin (100%), cephalothin (93%), cefamandole (80%), streptomycin (67%), and gentamicin (20%). Preoperative methicillin-susceptible isolates were generally susceptible to other antibiotics. Two patients with S. epidermidis prosthetic valve endocariditis caused by multiple antibiotic-resistant isolates were among the study patients. Antibiotic susceptibility patterns of each isolate from these two patients were identical to those of postoperative chest isolates from the same patient.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6901475      PMCID: PMC283770          DOI: 10.1128/AAC.17.2.269

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  8 in total

1.  Epidemiologic features and phage types associated with nosocomial infections caused by Staphylococcus epidermidis.

Authors:  L E Blouse; G D Lathrop; L N Kolonel; R M Brockett
Journal:  Zentralbl Bakteriol Orig A       Date:  1978-07

2.  Development of a bacteriophage-typing set for Staphylococcus epidermidis.

Authors:  J M Skahan; J T Parisi
Journal:  J Clin Microbiol       Date:  1977-07       Impact factor: 5.948

3.  Prosthetic valve endocarditis. Analysis of 38 cases.

Authors:  W E Dismukes; A W Karchmer; M J Buckley; W G Austen; M N Swartz
Journal:  Circulation       Date:  1973-08       Impact factor: 29.690

4.  Methicillin resistance in Staphylococcus epidermidis epidemiologic studies.

Authors:  D W Bentley
Journal:  Contrib Microbiol Immunol       Date:  1973

5.  Ivestigation of coagulase-negative staphylococci from infections in surgical patients.

Authors:  R R Marples; R Hone; C M Notley; J F Richardson; J A Crees-Morris
Journal:  Zentralbl Bakteriol Orig A       Date:  1978-07

6.  Rifampin therapy of Staphylococcus epidermidis. Use in infections from indwelling artificial devices.

Authors:  G L Archer; M J Tenenbaum; H B Haywood
Journal:  JAMA       Date:  1978-08-25       Impact factor: 56.272

7.  Antibiotic therapy of experimental Staphylococcus epidermidis endocarditis.

Authors:  G J Vazquez; G L Archer
Journal:  Antimicrob Agents Chemother       Date:  1980-02       Impact factor: 5.191

8.  Antimicrobial susceptibility and selection of resistance among Staphylococcus epidermidis isolates recovered from patients with infections of indwelling foreign devices.

Authors:  G L Archer
Journal:  Antimicrob Agents Chemother       Date:  1978-09       Impact factor: 5.191

  8 in total
  24 in total

1.  Characterization of clinically significant isolates of Staphylococcus epidermidis from patients with endocarditis.

Authors:  J Etienne; Y Brun; N el Solh; V Delorme; C Mouren; M Bes; J Fleurette
Journal:  J Clin Microbiol       Date:  1988-04       Impact factor: 5.948

2.  Increased resistance among Staphylococcus epidermidis isolates in a large teaching hospital over a 12-year period.

Authors:  O Lyytikäinen; M Vaara; E Järviluoma; K Rosenqvist; L Tiittanen; V Valtonen
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1996-02       Impact factor: 3.267

Review 3.  Coagulase-negative staphylococci and the epidemiological typing of Staphylococcus epidermidis.

Authors:  J T Parisi
Journal:  Microbiol Rev       Date:  1985-06

4.  Characterization of clinically significant isolates of Staphylococcus epidermidis from patients with cerebrospinal fluid shunt infections.

Authors:  J Etienne; B Charpin; J Grando; Y Brun; M Bes; J Fleurette
Journal:  Epidemiol Infect       Date:  1991-06       Impact factor: 2.451

5.  In vitro activity of six antibiotics against multiresistant staphylococci and other gram-positive cocci.

Authors:  S Dixson; W Brumfitt; J M Hamilton-Miller
Journal:  Eur J Clin Microbiol       Date:  1985-02       Impact factor: 3.267

6.  Antibiotic prophylaxis in cardiothoracic surgery in the United Kingdom: current practice.

Authors:  A P Wilson; T Treasure; M F Sturridge; R N Grüneberg
Journal:  Thorax       Date:  1986-05       Impact factor: 9.139

7.  Plasmid analysis as an epidemiological tool in neurosurgical infections with coagulase-negative staphylococci.

Authors:  A Ortqvist; U Ransjö; B Wretlind
Journal:  Epidemiol Infect       Date:  1987-06       Impact factor: 2.451

Review 8.  Current problems of chemotherapy of infections with coagulase-negative staphylococci.

Authors:  A J Davies; J W Stone
Journal:  Eur J Clin Microbiol       Date:  1986-06       Impact factor: 3.267

9.  Species identification of coagulase-negative staphylococcal isolates from blood cultures.

Authors:  R H Eng; C Wang; A Person; T E Kiehn; D Armstrong
Journal:  J Clin Microbiol       Date:  1982-03       Impact factor: 5.948

10.  Sequential analysis of staphylococcal colonization of body surfaces of patients undergoing vascular surgery.

Authors:  M F Levy; D D Schmitt; C E Edmiston; D F Bandyk; C J Krepel; G R Seabrook; J B Towne
Journal:  J Clin Microbiol       Date:  1990-04       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.